Skip to main content
Anteris Technologies Global Corp. logo

Anteris Technologies Global Corp. — Investor Relations & Filings

Ticker · AVR ISIN · US03675P1021 ASX Manufacturing
Open in API
Filings indexed 1,665 across all filing types
Latest filing 2016-10-06 Regulatory Filings
Country US United States of America
Listing ASX AVR

About Anteris Technologies Global Corp.

https://anteristech.com/

Anteris Technologies is a structural heart company focused on the development and commercialization of medical devices for heart valve disease. Its lead product is the DurAVR® Transcatheter Heart Valve (THV), a biomimetic valve designed for patients with severe aortic stenosis. The DurAVR® THV is engineered to mimic the performance of a healthy human aortic valve, aiming to restore normal, laminar blood flow. Clinical studies have shown the device delivers a favorable hemodynamic profile, characterized by low pressure gradients and a significant reduction in prosthesis-patient mismatch (PPM), even in patients with challenging anatomies. The company is advancing its technology through pivotal clinical trials to establish a new standard in transcatheter aortic valve replacement (TAVR) and improve long-term patient outcomes.

Recent filings

Filing Released Lang Actions
Waiver from Listing Rule 10.13.5 2 pages 197.9KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement regarding a waiver from ASX Listing Rule 10.13.5 related to the issuance of shares to directors in lieu of fees. It discusses conditions for the waiver and references notices of annual general meetings but does not contain financial statements, detailed financial data, or comprehensive report content. The document is relatively short (3395 characters) and serves as a regulatory announcement about a waiver and share issuance terms rather than a full report or detailed financial disclosure. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2016-10-06 English
Admedus Strengthens Management Team 2 pages 426.9KB
Board/Management Information Classification · 95% confidence The document is a company announcement dated 25th September 2016 from Admedus Ltd. It focuses on management team changes, specifically new appointments to strengthen revenue generation and sales growth. There is no detailed financial data, quarterly or annual results, or audit information. The content is about management restructuring and appointments, which aligns with announcements about changes in the company's board or senior management. The document length is 4834 characters, which is sufficient for a detailed announcement but does not contain financial statements or report data. Therefore, the document fits best under Board/Management Information (MANG).
2016-09-25 English
Appendix 3B - ESOP 14 pages 1.1MB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 3B form submitted to the Australian Stock Exchange (ASX) by Admedus Ltd. It details the issuance of 575,000 unlisted options to employees under an Employee Share Option Plan, including terms such as exercise price and expiry date. The document includes detailed information about the securities issued, compliance with ASX listing rules, and calculation of placement capacity under ASX rules 7.1 and 7.1A. This type of filing is a formal announcement of a capital raising or share issue event, specifically the issuance of new options. It is not a financial report, earnings release, or management discussion. It is a regulatory announcement about a capital/financing activity. Therefore, the correct classification is Capital/Financing Update (CAP). The document length and detail confirm it is not a brief announcement or a report publication announcement, but a substantive capital issuance filing.
2016-09-18 English
Settlement of Federal Court Proceedings 2 pages 363.3KB
Legal Proceedings Report Classification · 95% confidence The document is an ASX announcement from Admedus Ltd dated 9 September 2016. It announces the settlement of Federal Court proceedings related to ownership of regenerative technology. The content focuses on the resolution of litigation, its impact on the company, and future business prospects. There are no financial statements, quarterly or annual results, or detailed financial data presented. The document is a legal proceedings update rather than a full audit report or annual/interim report. It does not fit categories like Annual Report, Interim Report, or Earnings Release. The best fitting category is Legal Proceedings Report (LTR) as it provides an update on significant legal matters involving the company.
2016-09-08 English
Appendix 3B 16 pages 1.0MB
Capital/Financing Update Classification · 100% confidence The document is an Appendix 3B filing, which is a standard form used on the Australian Stock Exchange (ASX) for announcements related to new issues of securities, allotments, and applications for quotation of additional securities. The text details the allotment of new ordinary shares, the terms of the entitlement offer, underwriting details, and the application for quotation of these securities on the ASX. It is not a financial report, earnings release, or management discussion, but rather a formal announcement of a capital raising event and share issuance. This fits the definition of a Capital/Financing Update (CAP) as it provides updates on company fundraising and capital structure changes.
2016-09-05 English
Top 20 securityholders 2 pages 35.5KB
Major Shareholding Notification Classification · 100% confidence The document lists the top 20 shareholders of Admedus Limited with their shareholdings and percentages as of a specific date (06 Sep 2016). This is a notification of significant share ownership levels, showing detailed major shareholding information. There is no indication of a full report, financial statements, or other types of filings. The content matches the definition of a Major Shareholding Notification (MRQ). The document length is short and focused solely on shareholding data, confirming the classification.
2016-09-05 English

Browse filings by year

23 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.